Your browser doesn't support javascript.
loading
ALSUntangled #62: vitamin C.
Bedlack, Richard; Barkhaus, Paul; Carter, Greg; Crayle, Jesse; Mcdermott, Christopher; Pattee, Gary; Polak, Meraida; Salmon, Kristiana; Wicks, Paul.
Afiliación
  • Bedlack R; Department of Neurology, Duke University, Durham, NC, USA.
  • Barkhaus P; Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Carter G; Department of Rehabilitation Medicine, University of Washington, Seattle, WA, USA.
  • Crayle J; Department of Neurology, Washington University in St Louis School of Medicine, St Louis, MO, USA.
  • Mcdermott C; Department of Neuroscience, The University of Sheffield Institute for Translational Neuroscience, Sheffield, United Kingdom of Great Britain and Northern Ireland.
  • Pattee G; Department of Neurology, Neurology Associates, Lincoln, NE, USA.
  • Polak M; Department of Neurology, Emory Healthcare, Atlanta, GA, USA.
  • Salmon K; Department of Neurology, McGill Centre for Research in Neuroscience, Montreal, Canada.
  • Wicks P; UIndependent Consultant, United Kingdom of Great Britain and Northern Ireland.
Article en En | MEDLINE | ID: mdl-34187257
ABSTRACT
Vitamin C is one of the most common supplements taken by people with ALS. As an antioxidant, it has a plausible mechanism for slowing disease progression and there are some flawed pre-clinical studies and case reports suggesting benefit. However, a small human trial showed no benefit. Given this negative trial, we do not currently advise vitamin C as an ALS treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ácido Ascórbico / Vitaminas / Esclerosis Amiotrófica Lateral Límite: Humans Idioma: En Revista: Amyotroph Lateral Scler Frontotemporal Degener Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ácido Ascórbico / Vitaminas / Esclerosis Amiotrófica Lateral Límite: Humans Idioma: En Revista: Amyotroph Lateral Scler Frontotemporal Degener Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
...